A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.

Tedesco KL, Berlin J, Rothenberg M, Choy H, Wyman K, Scott Pearson A, Daniel Beauchamp R, Merchant N, Lockhart AC, Shyr Y, Caillouette C, Chakravarthy B
Radiother Oncol. 2005 76 (1): 54-8

PMID: 15921772 · DOI:10.1016/j.radonc.2005.04.005

MeSH Terms (12)

Adenocarcinoma Administration, Oral Aged Camptothecin Female Humans Male Middle Aged Pancreatic Neoplasms Radiation-Sensitizing Agents Radiotherapy Radiotherapy Dosage

Connections (2)

This publication is referenced by other Labnodes entities: